Imidazo[4,5-c]pyridine compound and method of antiviral treatment

Abstract

The compound 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, together with the salts and solvates thereof. Also provided are compositions comprising this compound and pharmaceutically acceptable carriers, as well as the use of such compositions in the treatment or prophylaxis of viral infections.

1 . 5-((3-(2,4-trifluoromethyphenyl)isoxazol-5-yl)methyl)-2-(2-fluorophenyl)-5H-imidazo[4,5-c]pyridine, and its salts and solvates.  
   
   
       2 . A composition comprising the compound of  claim 1  and at least one pharmaceutically acceptable carrier.  
   
   
       3 . A method for treatment or prophylaxis of a viral infection comprising administering to a subject an antiviral amount of a compound of  claim 1 .  
   
   
       4 . The method of  claim 3  wherein the viral infection is HCV.  
   
   
       5 . The compound of  claim 1  as the free base.